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Abstract
The cardiac stroma contains multipotent mesenchymal progenitors. However, lineage relationships within cardiac stromal cells are still poorly understood. Here, we identify heartresident PDGFRa + Sca-1 + cells as cardiac Fibro/Adipogenic Progenitors (cFAPs) and show that they respond to ischemic damage by generating fibrogenic cells. Pharmacological blockade of this differentiation step with an anti-fibrotic tyrosine kinase inhibitor decreases post-myocardial infarction (MI) remodeling and leads to improvements in heart function. In the undamaged heart, activation of cFAPs through lineage-specific deletion of the quiescence factor Hic1 reveals additional pathogenic potential, causing fibro-fatty infiltration of the myocardium and driving major pathological features of Arrhythmogenic Cardiomyopathy (AC).
Highlights
• A subpopulation of PDGFRa + , Sca-1 + cells, previously considered to be a sub-type of cardiac fibroblasts, are multipotent mesenchymal progenitors,
• Cardiac damage triggers the differentiation of PDGFRa + Sca-1 + cells into Sca-1 -cells expressing a fibrogenic transcriptional programme,
• Blockade of the cFAP-to-fibroblast transition by Nilotinib ameliorated cardiac dysfunction post-MI and modulated cardiac remodelling.
• Studies performed on a model of experimentally-induced AC confirmed that cFAPs are a source of both cardiac fibroblasts and adipocytes in vivo.
• Conversely, in the undamaged heart, activation of cFAPs by means of lineage-specific deletion of transcription factor Hic1, resulted in fibro/fatty cardiac degeneration and pathological alterations reminiscent of AC. Collectively, our findings show that a proportion of what are commonly termed "fibroblasts" are actually multipotent
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Others and us have identified a population of tissue-resident multipotent stromal cells in skeletal muscle that is characterized by the expression of PDGFRa and the stem cell marker Sca-1 (Joe et al., 2010; Uezumi et al., 2010) . These cells are referred to as Fibro Adipogenic Progenitors (FAPs) due to their spontaneous ability to generate fibroblasts as well as adipocytes in vivo and in vitro. In addition, they can be induced to acquire an osteogenic fate upon treatment with BMP2, further supporting the notion that FAPs are multipotent progenitors. Phenotypically identical cells with similar developmental potential were also found in numerous other tissues, including bone, kidney, skin (Festa et al., 2011) , fat (Chun et al., 2013) and the heart (Chong et al., 2011) . These populations have been demonstrated to possess highly similar transcriptomes, albeit with some tissue-specific differences in gene expression patterns (Pelekanos et al., 2012) .
Interestingly, unlike in skeletal muscle where all PDGFRa + cells express the stem cell marker Sca-1, in the adult heart at steady state, a subpopulation of PDGFRa + cells are Sca-1 -. These Sca-1 -cells are likely to represent a terminally differentiated population as they have limited proliferative capacity and they do not clonally expand in culture (Chong et al., 2011 ).
Here we show that a surprisingly large fraction of stromal cells previously thought to be cardiac fibroblasts are in fact multipotent progenitors, as defined by their in vivo and in vitro lineage capabilities. We find that these progenitors generate PDGFRa + , Sca-1 -fibroblasts upon injury, and pharmacological inhibition of this differentiation step improves cardiac function following myocardial infarction. Of note, we also report that impairing the ability of these cells to remain quiescent by deletion of transcription factor Hic1 leads to fibrofatty infiltration and arrhythmias in the absence of primary cardiomyocyte damage. Consistent with this, lowering the threshold of activation of cFAPs in a model of arrhythmogenic cardiomyopathy (AC) leads to earlier onset and increased severity of the pathology.
Results
Hic1 expression identifies a population of cardiac stromal cells enriched in multipotent mesenchymal progenitors.
Hic1 has been recently proposed as a transcription factor expressed in stromal progenitor cells (Underhill, ISSCR meeting 2014) . In order to analyze the population of Hic1-expressing cardiac cells within the heart and gain a better understanding of their lineage capabilities in vivo, we took advantage of a double transgenic mouse carrying both tamoxifen ( an as yet uncharacterized PDGFRa -, Sca-1 -cell type expressing pericytic markers that will be the subject of future study (Suppl. Fig. S1B ).
Expression of PDGFRa is commonly used to identify stromal cells in the heart and other tissues (Joe et al., 2010; Uezumi et al., 2010) . However, this population is highly heterogeneous, and likely to comprise multiple functionally different subsets. Indeed, cluster analysis of the PDGFRa+ cells revealed 6 different subclusters (Fig. 1B middle) . Interestingly, cells expressing highest levels of the progenitor cell marker Sca-1 (Fig. 1B right) were assigned to the same subcluster (subcluster 3 shown in Fig. 1B and Suppl. Fig. S1C ), suggesting that expression of this marker may identify a cell type expressing a distinctive transcriptional programme within the Hic1 Cre ERT2 tdTomato + PDGFRa + cells. Suppl. Fig. S1D shows a heatmap of the top 10 most differentially expressed genes in each of the PDGFRa + subclusters.
To further investigate the relationship between Sca-1 and Hic1 expression we compared cells purified from hearts of Hic1Cre ERT2 /tdTomato mice and from mice carrying citrine GFP knocked into the Hic1 locus (Hic1-citrine), which labels only cells expressing Hic1 and not their progeny (Pospichalova et al., 2011) . We found that while Hic1 expression, after excluding pericytes, was mostly restricted to cells expressing Sca-1 (Fig. 1C, i) , their tdTomato + progeny included a fraction of Sca-1 -cells (Fig. 1C , ii). Based on our previous studies in the skeletal muscle (Joe et al., 2010; Uezumi et al., 2010) (Ieronimakis et al., 2013 ) (Suppl. Fig. S1E ). Deeper transcriptional analysis of the Sca-1 + and Sca-1 -populations using bulk RNAseq showed that the Sca-1 + population expressed significantly higher levels of progenitor markers including CD90, CD44 and CD34 (Fig. 1E) . In contrast to previous reports (Ieronimakis et al., 2013 ) however, we failed to detect distinct anatomical locations for cardiac PDGFRa + /Sca-1 + and PDGFRa + /Sca-1 -cells, which we found to be in close proximity ( Fig. 1F and Suppl. Fig. S1F ).
Thus, in the resting heart, both Sca-1 + and Sca-1 -cell types express similar transcriptional programmes indicative of a fibrogenic potential, and their transcriptome or anatomical location fails to point towards obvious functional differences between them. (Fig. 1G) . However, similar to what was reported by Chong et al. (Ieronimakis et al., 2013) , we were unable to achieve reliable cell growth of Sca-1 -cells in vitro in clonal or bulk conditions, suggesting that this subset may be further differentiated (Suppl. Fig. S1G ). To assess whether the PDGFRa, Sca-1 + cells contain all adipogenic activity detectable in the heart, bulk cultures from PDGFRaCre ERT2 /Tdtomato mice, characterized in Suppl. Fig. 2A -B, were expanded in adipogenic media. As shown in figure 1H , the vast majority of perilipin + adipocytes were also tdTomato + , suggesting that PDGFRa + cells are the main contributor to adipocyte formation in the heart. Thus, a significant proportion of PDGFRa + /Sca-1 + cells, a population that has been previously defined as cardiac fibroblasts (Pinto et al., 2016) , behave as multipotent mesenchymal progenitors in vitro, similar to skeletal muscle-derived FAPs (Joe et al., 2010; Uezumi et al., 2010) .
Stromal dynamics in the acutely damaged myocardium
To assess the response of cardiac PDGFRa + cells to myocardial injury, we induced an experimental infarction by ligation of the left anterior descending coronary artery (LAD) in PDGFRa H2BGFP mice (Hamilton et al., 2003) , characterized in Suppl. Fig. 2C . This resulted in a significant increase in PDGFRa cells ( Fig. 2A) , correlating with proliferation in the damaged region of the heart proximal to the apex, where more than 30% of EdU + cells were GFP + ( Fig.   2A, B) . In contrast to skeletal muscle injury, where upon successful regeneration FAPs numbers rapidly return to steady state levels, the increase in cFAPs after damage is sustained in time ( Fig. 2A) . Additionally, in contrast to undamaged areas where the majority of PDGFRa + cells remained positive for Sca-1, we observed a time-dependent decrease in the ratio of Sca-1 + to
Sca-1 -cells in the damaged heart apex ( Fig. 2C ). Since infarction often does not affect the full thickness of the left ventricular wall, we focused our analysis on the damaged areas, identified by the presence of collagen deposits. In these locations, more than 80% of the GFP + cells failed to stain for Sca-1 (Fig. 2D and Suppl. Fig. S3A ). Thus, Sca-1 negative cells increase upon damage, and they preferentially localize to areas of collagen deposition. (Fig. 3C ). However, expression of genes associated with pathogenic matrix deposition was significantly enriched in the Sca-1 -fraction 1 and 2 weeks following damage, confirming that these cells assume an activated fibrogenic phenotype ( Fig. 3C ). In accordance with this, t-SNE clustering of scRNAseq data from cardiac Hic1Cre ERT2 /tdTomato + cells 7 days after LAD ligation revealed 2 spatially distinct clusters expressing PDGFRa, one of which expressed lower levels of Sca-1 and Hic1 but was highly enriched for ECM-related genes as well as the activated fibroblast marker periostin (Kanisicak et al., 2016) (Fig. 3D ).
PDGFRa
Clustering analysis revealed that the PDGFRa+ cells retained their heterogeneity after damage ( Fig. 3D ) and that the cells expressing highest levels of Sca-1 were still clustered together (subcluster 3 shown in Fig. 3D and Suppl. Fig. S4A ). Suppl. Fig. S4B shows a heatmap of the top 10 most differentially expressed genes in each of the PDGFRa + subclusters.
Interestingly, when the cFAPs were sub-clustered and clusters were organized in a phylogenetic tree, the resulting hierarchy correlated with the levels of Sca-1 expression in each cluster ( Fig.   3E ) further supporting the hypothesis that cells downregulate Sca-1 as they differentiate along the fibrogenic lineage and suggesting that multiple intermediates may be generated during such transition.
Clustering of the merged scRNAseq datasets for Hic1Cre ERT2 /tdTomato + cells before and after damage (Suppl. Fig. S4B ) revealed that FAPs from damaged samples clustered separately from those at steady state (Suppl. Fig. S4C ). Gene Ontology Analysis of the differentially upregulated genes in each cluster (Suppl. Fig. S4D ) pointed to the upregulation of multiple biosynthetic pathways upon FAP activation, and of ECM production-related as well as pro-angiogenic pathways upon loss of Sca-1 and differentiation.
Taken together, these results strongly suggest that in response to damage, cFAPs differentiate into fibrogenic cells while downregulating progenitor markers such as Sca-1 and Hic1.
Inhibition of FAPs differentiation improves cardiac performance.
Excessive generation of fibrogenic matrix causes heart wall stiffening, resulting in impaired cardiac contractile function (Gyöngyösi et al., 2017) . We reasoned that inhibiting the differentiation of cFAPs towards Sca-1 -fibrogenic cells may have a therapeutic effect following myocardial infarction. We previously identified members of the imatinib/nilotinib tyrosine kinase inhibitor (TKI) family as modulators of FAP survival (Lemos et al., 2015) . Further analysis revealed that these compounds are also capable of blocking the upregulation of collagen in TGFb-treated cFAPs in vitro (Fig. 4A ). Thus, we investigated whether nilotinib (25mg/kg/day) could ameliorate ISO-induced cardiac damage. Mice were treated with ISO for 5 days, and with nilotinib for the following 7 days. The latter treatment prevented the decrease in the Sca-1 + /Sca-1 -ratio observed with ISO alone (Fig. 4B ) and significantly reduced fibrotic lesion formation (Fig.   4C, D) , supporting the hypothesis that nilotinib acts, at least in part, by blocking pro-fibrotic differentiation of cFAPs and loss of Sca-1 expression. As cardiac function was not significantly impacted by ISO treatment, we sought to establish the therapeutic potential of blocking cFAPdriven fibrogenesis in the more severe LAD coronary artery ligation model. Three days after surgery, mice were treated with nilotinib (25mg/kg/day) for 28 days, after which cardiac function was assessed. We delayed the start of the treatment to avoid interfering with the initial steps of scar formation, as this has been shown to be deleterious (Frantz et al., 2008; IKEUCHI et al., 2004) , and to more closely mimic the likely timing of administration of similar drugs to human patients.
In the untreated mice, LAD ligation produced a progressive decline in LV ejection fraction. This was associated with elevated end-diastolic volume (a hallmark of cardiac compromise), as well as increased anterior and posterior LV wall thickness and LV chamber dilation, features of cardiac remodeling (Fig. 4E) . Interestingly, nilotinib treatment attenuated the decline in ejection fraction and completely prevented the elevation in end-diastolic volume, LV chamber dilation and LV posterior wall thickening. Similar to ISO injury model, nilotinib treatment was also associated with a significant increase in the PDGFRa + Sca-1 + /Sca-1 -ratio (Fig. 4E) . Thus, the differentiation step leading to the generation of fibrogenic cells from cFAPs can be pharmacologically targeted to improve post-MI cardiac performance.
A role for cFAPs in the pathogenesis of arrhythmogenic cardiomyopathy (AC).
While adipogenic differentiation of cFAPs was readily observed in vitro, their activation following ischemic damage does not lead to the appearance of intramyocardial adipocytes. However, adipocyte accumulation is a well-documented outcome of Arrhythmogenic Cardiomyopathy (AC), an inherited cardiac disease characterized by degenerative replacement of myocardium with fibrofatty infiltrations leading to life threatening arrhythmias and sudden death, especially in young adults (Basso et al., 2009 ).
To confirm the adipogenic potential of cFAPs in vivo, we generated a model of this disease by overexpressing human desmoglein 2 (DSG2) carrying a pathogenic 1672C ®T mutation (Pilichou et al., 2006) in mice. In this model, fibrous and/or fatty infiltrations develop by 9 months of age, and adipocytes have been shown to ail from cells originating from a PDGFRa precursor. However, as a non-inducible PDGFRa-CRE was used, it is unclear if this marker expression took place during development or in the adult heart (Lombardi et al., 2016) . To assess whether such infiltrations originate from Hic1 + cells, we bred the tdTomato reporter and either the Hic1Cre ERT2 or the PDGFRaCre ERT2 transgenes into this strain (Fig. 5A, D) . Consistent with the ischemic injury models, Hic1 or PDGFRa traced cells were enriched in areas of collagen deposition (Fig. 5B, E) . In addition, the majority of infiltrating adipocytes were tdTomato + (Fig. 5C, F (Fig. 6A ). Immunohistochemical analysis of Hic1 KO, but not control heart sections 6 months to 1 year after TAM treatment revealed epicardial and/or interstitial fibrosis as well as intramyocardial adipocyte infiltrations (Fig. 6B ). In these mice, cardiac function was compromised as illustrated by reduced LV Ejection fraction as well as increased myocardial performance index (MPI), isovolumic relaxation time (IVRT) and mitral valve (MV) deceleration time ( Fig. 6C, D) . Additionally, ECG tracings of Hic1 KO mice hearts showed arrhythmias in the form of premature ventricular contractions as well as notched QRS complexes (white arrows in Fig. 6C ). To evaluate the systemic effects of these changes, we subjected these mice to forced exercise and assessed their endurance. The distance and speed reached until fatigue (as 14 defined in the methods section) were significantly lower in Hic1 KO mice than in the control mice (Fig. 6E ).
The UBCCre ERT2 Hic1 Fl/LacZ deletes Hic1 in both PDGFRa positive and negative cells, making it more difficult to attribute the observed phenotype exclusively to cFAPs versus the minor, Hic1 expressing pericytic population described above. To bypass this confound, we bred Hic1
Fl/Fl mice with PDGFRaCre ERT2 /tdTomato mice and confirmed that the vast majority of cells composing the lesions originated from PDGFRa + cFAPs (Suppl. Fig. S5A ). As expected, these mice also developed signs of cardiac dysfunction comparable with those described above (Suppl. Fig. S5B and C). To further explore whether Hic1 may be a modifier of the penetrance of AC, we crossed the DSG2 mu mice with PDGFRaCre ERT2 /Hic1 Fl/Fl mice and compared them to their parental strains. At 6 months of age and 1 month after TAM treatment, adipocytic infiltration was limited in the DSG2 mu mice (as at this age DSG2 mu mice do not display overt lesions yet), while significantly increased in the other two strains, with mice harboring both the DSG mutation and the Hic1 KO having approximately double the adipocytes than the Hic1KO mice (Suppl. Fig. S5D ). Thus, damage-independent activation of FAPs leads to fibrous/fatty infiltration and arrhythmias reminiscent of human AC even in the absence of cardiac damage, and accelerates fat deposition in the presence of subclinical damage, underpinning the key role played by these cells in AC pathophysiology.
Discussion
The cellular mechanisms leading to cardiac fibrosis and fatty degeneration remain poorly understood. Over the past several years, various markers have been proposed to identify cardiac fibroblasts, including multiple lineage tracing tools, such as PDGFRa, TCF21 and collagen1. However, despite reports that multipotent progenitors are also contained within these populations (Chong et al., 2011) Thus, unlike what was previously described for mesenchymal stem cells (Noseda et al., 2015; Ubil et al., 2014) , their multipotency is restricted to connective tissue elements. In view of their predominant fates in vitro and in vivo, and in keeping with the nomenclature in use in skeletal muscle, we propose that PDGFRa, Sca-1, Hic1 positive cells be called cardiac fibro/adipogenic progenitors (cFAPs) as used in this study.
We identify a differentiation hierarchy within cardiac PDGFRa + cells, with cFAPs constantly generating a small number of post-mitotic, Sca-1 -differentiated cells in the undamaged heart. A caveat of this interpretation lies in the fact that TAM treatment, at the dosage used, can be cardiotoxic (Bersell et al., 2013) . At homeostasis, both cFAPS and their progeny express low levels of pathogenic ECM genes, but following damage these genes, as well as the recently proposed activated fibroblast marker periostin (Kanisicak et al., 2016) and active, and it suggests that therapeutic interventions modulating fibrosis should be deployed not immediately after an ischemic event to allow for scar formation, but rather within the first few days following damage.
Inhibition of such differentiation step using nilotinib, a second generation anti-leukemic TKI, led to an improvement of heart function following an ischemic infarct and reduced the generation of Sca-1 -cells from cFAPs. Consistent with these results Imatinib, an earlier member of the same TKI family, was shown to also have favorable effects on rat cardiac function after MI (Liu et al., 2014) . While our experiments provide clear proof of principle that modulation of cFAP differentiation is a viable therapeutic strategy, the reported cardiotoxicity of nilotinib (Moslehi and Deininger, 2015) raises questions about whether its long term use in infarct patients is appropriate, and provides a strong rationale for testing alternative TKIs.
By performing lineage tracing in a mouse model of AC, we show that the Hic1 + subset of PDGFRa + cells is responsible for the generation of the intramyocardial adipocytes pathognomonic of this disease. This is in stark contrast with these cells' exclusive generation of fibrogenic progeny in the context of myocardial infarction, suggesting that the extent or the type of damage inflicted is likely to modulate their lineage choice through mechanisms as yet unclear. This is consistent with the upregulation of known anti-adipogenic factors such as TGFb and Wnts following an MI (Blankesteijn et al., 2000; Deten et al., 2001 ).
cFAPs' quiescence can be prevented by deleting Hic1, a transcriptional repressor that modulates the expression of cell-cycle related genes (Scott et al, in preparation). In the heart, this led to a rapid increase in cFAP numbers followed by the slower appearance of intramyocardial adipocytes and fibrosis, and eventually clinical signs reminiscent of human AC and reduced running performance. This suggests that the main effects of the desmosomal mutations linked to AC may be to cause the chronic activation of cFAPs, which represents the key pathogenic event. Consistent with this hypothesis, lack of Hic1 cooperates with AC-inducing mutations in accelerating the appearance of intramyocardial adipocytes.
Our work reveals that a significant proportion of cells meeting the phenotypic definition of cardiac fibroblasts are actually multipotent progenitors, identifies the quiescence regulator Hic1 as a marker for these cells, and points to their significant role in the pathology of human AC. It also suggests that following ischemic damage, TKIs can be used to modulate the appearance of fibrogenic cells with positive results on cardiac performance, providing a rationale for exploring a novel therapeutic strategy for one of the most common diseases of our time.
Methods
Animals
PDGFRa H2BGFP mice were purchased from Jackson Laboratories and Col1a1-3.6GFP mice were a gift from Dr. David W. Rowe (Center for Regenerative Medicine and Skeletal Development, University of Connecticut Health Center). For generation of PDGFRa Cre ERT2 "knock-in" allele, a Cre ERT2 polyA cassette and a FRT -flanked neo cassette were recombined into the start codon of Pdgfra. The construct was electroporated into TL1 (129S6/SvEvTac) ES cells and these were injected into C57BL/6 blastocysts. The neo cassette was removed.
PDGFRa Cre ERT2 mice are maintained on a C57BL/6 background. Mice harboring Hic1 Cre ERT2 , or Hic1 Fl/Fl alleles were generated in the Underhill lab while mice harboring Hic1 citrine were generated by the Korinek lab (Pospichalova et al., 2011 
Heart digestion and flow cytometry
Mice were sacrificed, their hearts carefully excised and cut into 2mm pieces. A single cell suspension was made by digesting tissue for 30 minutes at 37°C in Collagenase type 2 solution (Worthington Biochemical; 500uL per heart of 2.5 U/ml) in 10 mM CaCl2. Suspensions were then centrifuged at 800 rpm and supernatant decanted. This was repeated twice followed by incubation for 1 hour at 37°C in a solution containing Collagenase D (Roche; 1.5 U/ml), Dispase II (Sigma-Aldrich; 2.4 U/ml) and 10 mM CaCl 2 . Following washing and filtration with 70 µm mesh filters, cell preparations were incubated with primary antibodies against cell membrane markers for 30 min at 4 °C in supplemented PBS containing 2 mM EDTA and 2% FBS (FACS buffer) at ~3 × 107 cells/ml. The antibodies used in flow cytometry and the dilutions are listed on Table S1 of Supplementary Information.
For in vivo proliferation assays, EdU (Thermo Fisher Scientific) was dissolved in PBS at 2 mg/ml solution and it was administered daily by intraperitoneal injection (40 mg/kg). For flow cytometric analysis, cells were first stained for surface markers, then stained for EdU incorporation using 
Histology and immunohistochemistry
Mice received an intraperitoneal injection of 0.5 mg/g Avertin, and were perfused transcardially with 20 ml PBS/ 2 mM EDTA, followed by 20 ml of 4% paraformaldehyde (PFA). The excised muscles were fixed in 4% PFA overnight. The following day, the tissue was either prepared for paraffin embedding following the standard sequence of dehydration steps in ethanol, or transferred to 30% sucrose in PBS and incubated overnight for subsequent optimal cutting temperature (OCT) formulation embedding and freezing. Standard methods were followed for cryosectioning and 10 µm tissue sections were either stained using Masson's Trichrome Stain 20 as previously described (Bostick et al., 2012) , or processed for immunohistochemistry as follows:
tissue sections were washed in 0.3% Triton X-100 (Sigma) in PBS, incubated in sodium borohydride solution (10 mg/ml) for 30 minutes and then blocked for 1 hour at room temperature in PBS containing 10% normal goat serum (NGS), 0.2% Triton X-100 and 5% bovine serum albumin (BSA). Sections were stained overnight at 4 °C using a primary antibody diluted in 10% NGS, 0.2% Triton X-100 and 5% BSA. The primary antibodies used for immunofluorescence are listed in Table S1 of Supplementary Information. In all cases, the primary antibody was detected using secondary antibodies conjugated to Alexa 488, 555, 594, or 647 (Molecular Probes).
Confocal microscopy was performed using a Nikon eclipse Ti Confocal Microscope with a C2 laser unit. Figures were assembled using Illustrator CS6 (Adobe).
Echocardiography
Cardiac function and dimensions were evaluated by two-dimensional transthoracic echocardiography. Echocardiographic image acquisition was carried out using the Vevo2100 system (Fujifilm Visualsonics). Mice were anaesthetized with 3-4% isoflurane in 100% oxygen.
Following induction, mice were placed on a heated handling table and anesthesia and body temperature were maintained at 1-1.5% isoflurane and 37 ± 0.5°C, respectively. All measurements were performed by a single experienced operator blinded to the mouse genotypes.
In vitro culturing experiments
Cells were sorted from digested hearts using indicated gating into high (4.5g/L) glucose 
Quantification of tdTomato colocalization with collagen I
Colocalization with collagen I immunostaining in heart sections was determined using ImageJ (Fiji v1 edition). Split channel images were generated and the area of fibrosis was highlighted.
Colocalization was determined using the colocalization thresholds plugin and a colocalized pixel map image was generated with constant intensity for colocalized pixels. % colocalization was determined as the % channel volume (number of voxels which have both channel 1 (collagen I) and channel 2 (tdTomato) intensities above threshold determined using Pearson's coefficient, expressed as a percentage of the total number of voxels for collagen I channel above its threshold.
Treadmill forced exercise test
Hic1 KO mice and their controls were subjected to low intensity short periods of exercise for 5
consecutive days for training purpose on a rodent treadmill equipped with shock grids to deliver very low level electrical stimulus when mice stop running (Columbus Instruments). After 2 days of rest, mice were run on the treadmill at a constant velocity of 10m/min and the distance travelled before fatigue (the time point at which mice are electrically shocked 3 consecutive times and do not respond by continuing to run) was determined. Alternatively, mice were subjected to increasing treadmill velocities (1m/min incremental increase every 50-meter run) and the velocity at which mice displayed fatigue was determined.
in situ X-gal staining
For in situ X-gal staining, mice were terminally anesthetized by intraperitoneal injection of Avertin (400 mg/kg), the chest was opened and hearts were perfused with cold LacZ fixative (100 mM Slides were counter-stained with nuclear fast red and mounted with Aqua Polymount.
Gene expression profiling -popRNA-seq
Total RNA was isolated using RNeasy Plus micro kit (Qiagen) as per manufacturer's instructions.
Sample integrity was tested on an Agilent Bioanalyzer 2100 RNA 6000 Nano kit (Agilent). RNA samples with a RNA Integrity Number > 8 were used for library preparation using the protocol for the TruSeq Stranded mRNA library kit (Illumina) on the Illumina Neoprep automated microfluidic library prep instrument. Paired end sequencing was performed on the Illumina NextSeq 500 using the High Output 150 cycle Kit (Illumina).
RNA-seq Bioinformatic Analyses
De-multiplexed read sequences were then aligned to the Mouse Genome mm10 reference sequence using TopHat splice junction mapper with Bowtie 2 (http://ccb.jhu.edu/software/tophat/index.shtml) or STAR (https://www.ncbi.nlm.nih.gov/pubmed/23104886) aligners. Assembly and differential expression was estimated using Cufflinks (http://cole-trapnell-lab.github.io/cufflinks/). Heatmap generation were performed with VisRseq (Younesy et al., 2015) (v.0.9-2.15 ).
Single Cell RNA-seq
Single cell suspensions were prepared by digesting the hearts and FACS-sorting target population into sterile-filtered culture medium (DMEM containing 5% FBS). Second sorting in 35µL medium was done to ensure high purity and quality of the cells. After the tdTomato + cell suspension was examined for quality and cells counted using a hemocytometer, they were delivered into a Chromium Controller (10 X Genomics), captured and libraried with the Chromium single cell 3' reagent kit v2 (10 X Genomics). cDNA libraries were sequenced on a Nextseq 500
(Illumina) to a minimum depth of 20,000 mean reads per cell. Demultiplexing, alignment to the modified mm10 reference genome, principal component analysis (PCA), clustering, non-linear reduction (t-SNE) and differential expression was performed using the cellranger count pipeline (10 X Genomics). Graphical output, merging and subsetting of datasets was performed using Seurat R package (Satija Lab, v.2.2) . Subsetting was performed by excluding the clusters that expressed pericytic markers in order to focus only on the cFAPs when building a phylogenetic tree or merging the datasets. Subsequently, PCA, graph-based clustering, t-SNE and Wilcoxon rank sum test for differential expression were performed with Seurat R package. Gene ontology analysis for the 50 most differentially upregulated genes in the different clusters was performed using the DAVID Bioinformatics Resources (Huang et al., 2009a (Huang et al., , 2009b .
Statistics
Power calculations were not done to predetermine sample size. We did not use any specific method of randomization to determine how samples and/or animals were allocated to experimental groups and processed. Analyses were not performed in a blinded fashion. No samples were excluded from the reported analyses. All results are presented as mean ± standard error of the mean (SEM). Statistical analysis was performed using unpaired Student's t-test for analysis between 2 groups followed by Tukey's post hoc test. For comparison between 25 number for each experiment is indicated in the figure legends. Results with p values of less than 0.05 were considered statistically significant.
Data availability
The bulk and single cell RNA sequencing datasets generated during the current study are available in the NCBI Gene Expression Omnibus (link will be provided upon manuscript acceptance). Data are represented as mean ± SEM. *p<0.05 compared to UBCCre ERT2 /Hic1 Fl/+ control mice.
